Actos pioglitazone HCI

You've taken Actos Pioglitazone HCI with Type 2 diabetes. You've been diagnosed with bladder cancer.

 

You have the right to know if you are eligible for compensation. 

 

CALL TODAY to get your case started.
(800) 600- 6014

You've taken Actos Pioglitazone HCI with Type 2 diabetes. You've been diagnosed with bladder cancer.

You have the right to know if you are eligible for compensation. 

Start your Free Consultation

* Name:

* Email:

Phone:

* Case Details:

*Required Fields

HELP OTHERS

Spread the word so that others, who have suffered from bladder cancer, can understand their rights.

Taking Actos has been found to increase the risk of bladder cancer by 40%.

It is alleged that Takeda Pharmaceuticals, (the maker of Actos pioglitazone HCI, also known as duetact, actoplus met, and actoplus met XR) was negligent in testing and developing Actos and they had knowledge of the bladder cancer risk associated with the drug.  

Takeda announced, inApril 2015, that it would pay up to $2.4 billion to settle Actos lawsuits.

Medical expenses and missed wages could be recovered if you took Actos before December of 2011 and were subsequently diagnosed with bladder cancer.  

 

At Goldberg Attorneys, we truly understand how devastating bladder cancer can be.  Our law firm is here to help you.  Call us today to find out if you have claim. 

CALL TODAY to get your case started.
(800) 600- 6014